Molecular determinants for a cardiovascular collapse in anthrax

Frontiers in Bioscience - Elite

Volumn 6 E, Issue 1, 2014, Pages 139-147

  Brojatsch, Jurgen ^a   Casadevall, Arturo ^a   Goldman, David L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anthrax; Apoptosis; MAPK; Nod like receptor; Review; Shock

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTHRAX TOXIN; IMMUNOLOGICAL ADJUVANT; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; VIRULENCE FACTOR;

ANTHRAX; BACILLUS ANTHRACIS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL TYPE; CELL WALL; CYTOKINE STORM; DISEASE COURSE; EDEMA; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART FAILURE; LIVER INJURY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; APOPTOSIS REGULATORY PROTEINS; BACILLUS ANTHRACIS; BACTERIAL CAPSULES; BACTERIAL TOXINS; CARDIOVASCULAR DISEASES; CELL WALL; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; LIVER; MAP KINASE SIGNALING SYSTEM; MICE; SHOCK;

EID: 84902513337     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. M. Moayeri and S. H. Leppla: Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol.Aspects Med., 30(6), 439-455 (2009)
2. X. Cui, M. Moayeri, Y. Li, X. Li, M. Haley, Y. Fitz, R. Correa-Araujo, S. M. Banks, S. H. Leppla and P. Q. Eichacker: Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am.J.Physiol Regul.Integr.Comp Physiol, 286(4), R699-R709 (2004)
3. N. C. Culley, D. M. Pinson, A. Chakrabarty, M. S. Mayo and S. M. Levine: Pathophysiological manifestations in mice exposed to anthrax lethal toxin. Infect.Immun., 73(10), 7006-7010 (2005)
4. D. J. Stearns-Kurosawa, F. Lupu, F. B. Taylor, Jr., G. Kinasewitz and S. Kurosawa: Sepsis and pathophysiology of anthrax in a nonhuman primate model. Am J Pathol, 169(2), 433-44 (2006)
5. L. M. Grinberg, F. A. Abramova, O. V. Yampolskaya, D. H. Walker and J. H. Smith: Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod.Pathol., 14(5), 482-495 (2001)
6. S. R. Kuo, M. C. Willingham, S. H. Bour, E. A. Andreas, S. K. Park, C. Jackson, N. S. Duesbery, S. H. Leppla, W. J. Tang and A. E. Frankel: Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb.Pathog. (2007)
7. J. A. Jernigan, D. S. Stephens, D. A. Ashford, C. Omenaca, M. S. Topiel, M. Galbraith, M. Tapper, T. L. Fisk, S. Zaki, T. Popovic, R. F. Meyer, C. P. Quinn, S. A. Harper, S. K. Fridkin, J. J. Sejvar, C. W. Shepard, M. McConnell, J. Guarner, W. J. Shieh, J. M. Malecki, J. L. Gerberding, J. M. Hughes and B. A. Perkins: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg.Infect.Dis., 7(6), 933-944 (2001)
8. B. Mina, J. P. Dym, F. Kuepper, R. Tso, C. Arrastia, I. Kaplounova, H. Faraj, A. Kwapniewski, C. M. Krol, M. Grosser, J. Glick, S. Fochios, A. Remolina, L. Vasovic, J. Moses, T. Robin, M. DeVita and M. L. Tapper: Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City. JAMA, 287(7), 858-62 (2002)
9. J. Guarner, J. A. Jernigan, W. J. Shieh, K. Tatti, L. M. Flannagan, D. S. Stephens, T. Popovic, D. A. Ashford, B. A. Perkins and S. R. Zaki: Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol, 163(2), 701-9 (2003)
10. H. M. Scobie, G. J. Rainey, K. A. Bradley and J. A. Young: Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A, 100(9), 5170-4 (2003)
11. K. A. Bradley, J. Mogridge, M. Mourez, R. J. Collier and J. A. Young: Identification of the cellular receptor for anthrax toxin. Nature, 414(6860), 225-9 (2001)
12. J. Mogridge, K. Cunningham, D. B. Lacy, M. Mourez and R. J. Collier: The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc Natl Acad Sci U S A, 99(10), 7045-8 (2002)
13. N. Abboud, M. De Jesus, A. Nakouzi, R. J. Cordero, M. Pujato, A. Fiser, J. Rivera and A. Casadevall: Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. The Journal of biological chemistry, 284(37), 25077-86 (2009)
14. V. A. Karginov, E. M. Nestorovich, M. Moayeri, S. H. Leppla and S. M. Bezrukov: Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design. Proc Natl Acad Sci U S A, 102(42), 15075-80 (2005)
15. C. Kim, N. Gajendran, H. W. Mittrucker, M. Weiwad, Y. H. Song, R. Hurwitz, M. Wilmanns, G. Fischer and S. H. Kaufmann: Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci U S A, 102(13), 4830-5 (2005)
16. W. L. Shoop, Y. Xiong, J. Wiltsie, A. Woods, J. Guo, J. V. Pivnichny, T. Felcetto, B. F. Michael, A. Bansal, R. T. Cummings, B. R. Cunningham, A. M. Friedlander, C. M. Douglas, S. B. Patel, D. Wisniewski, G. Scapin, S. P. Salowe, D. M. Zaller, K. T. Chapman, E. M. Scolnick, D. M. Schmatz, K. Bartizal, M. MacCoss and J. D. Hermes: Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A, 102(22), 7958-63 (2005)
17. S. Basha, P. Rai, V. Poon, A. Saraph, K. Gujraty, M. Y. Go, S. Sadacharan, M. Frost, J. Mogridge and R. S. Kane: Polyvalent inhibitors of anthrax toxin that target host receptors. Proc Natl Acad Sci U S A, 103(36), 13509-13 (2006)
18. S. Liu, D. Crown, S. Miller-Randolph, M. Moayeri, H. Wang, H. Hu, T. Morley and S. H. Leppla: Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A, 106(30), 12424-9 (2009)
19. K. R. Klimpel, N. Arora and S. H. Leppla: Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol.Microbiol., 13(6), 1093-1100 (1994)
20. N. S. Duesbery, C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull and G. F. Vande Woude: Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science, 280(5364), 734-7 (1998)
21. K. A. Hellmich, J. L. Levinsohn, R. Fattah, Z. L. Newman, N. Maier, I. Sastalla, S. Liu, S. H. Leppla and M. Moayeri: Anthrax lethal factor cleaves mouse nlrp1b in both toxin-sensitive and toxin-resistant macrophages. PLoS One, 7(11), e49741 (2012)
22. M. Moayeri and S. H. Leppla: The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol, 7(1), 19-24 (2004)
23. H. M. Koo, M. VanBrocklin, M. J. McWilliams, S. H. Leppla, N. S. Duesbery and G. F. Vande Woude: Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proc Natl Acad Sci U S A, 99(5), 3052-7 (2002)
24. J. M. Park, F. R. Greten, Z. W. Li and M. Karin: Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science, 297(5589), 2048-51 (2002)
25. N. H. Purcell, B. J. Wilkins, A. York, M. K. Saba-El-Leil, S. Meloche, J. Robbins and J. D. Molkentin: Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc Natl Acad Sci U S A, 104(35), 14074-9 (2007)
26. C. Dong, R. J. Davis and R. A. Flavell: MAP kinases in the immune response. Annu Rev Immunol, 20, 55-72 (2002)
27. A. Agrawal and B. Pulendran: Anthrax lethal toxin: a weapon of multisystem destruction. Cell Mol Life Sci, 61(22), 2859-65 (2004)
28. T. Fukao: Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect Dis, 4(3), 166-70 (2004)
29. D. C. Fish, F. Klein, R. E. Lincoln, J. S. Walker and J. P. Dobbs: Pathophysiological changes in the rat associated with anthrax toxin. The Journal of infectious diseases, 118(1), 114-24 (1968)
30. J. A. Vick, R. E. Lincoln, F. Klein, B. G. Mahlandt, J. S. Walker and D. C. Fish: Neurological and physiological responses of the primate to anthrax toxin. The Journal of infectious diseases, 118(1), 85-96 (1968)
31. A. M. Firoved, G. F. Miller, M. Moayeri, R. Kakkar, Y. Shen, J. F. Wiggins, E. M. McNally, W. J. Tang and S. H. Leppla: Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol, 167(5), 1309-20 (2005)
32. M. Moayeri, D. Haines, H. A. Young and S. H. Leppla: Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J.Clin.Invest, 112(5), 670-682 (2003)
33. L. E. Watson, J. Mock, H. Lal, G. Lu, R. W. Bourdeau, W. J. Tang, S. H. Leppla, D. E. Dostal and A. E. Frankel: Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction. Front Biosci., 12, 4670-4675 (2007)
34. S. Liu, Y. Zhang, M. Moayeri, J. Liu, D. Crown, R. J. Fattah, A. N. Wein, Z. X. Yu, T. Finkel and S. H. Leppla: Key tissue targets responsible for anthrax-toxin-induced lethality. Nature, 501(7465), 63-8 (2013)
35. J. Pandey and D. Warburton: Knock-on effect of anthrax lethal toxin on macrophages potentiates cytotoxicity to endothelial cells. Microbes.Infect., 6(9), 835-843 (2004)
36. J. E. Kirby: Anthrax lethal toxin induces human endothelial cell apoptosis. Infect.Immun., 72(1), 430-439 (2004)
37. R. E. Bolcome, 3rd, S. E. Sullivan, R. Zeller, A. P. Barker, R. J. Collier and J. Chan: Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature. Proc Natl Acad Sci U S A, 105(7), 2439-44 (2008)
38. Y. Li, X. Cui, S. B. Solomon, K. Remy, Y. Fitz and P. Q. Eichacker: B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine- stimulated contraction in a rat aortic ring model. Am J Physiol Heart Circ Physiol, 305(2), H238-50 (2013)
39. L. E. Watson, S. R. Kuo, K. Katki, T. Dang, S. K. Park, D. E. Dostal, W. J. Tang, S. H. Leppla and A. E. Frankel: Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLoS.ONE., 2(5), e466 (2007)
40. X. Cui, Y. Li, X. Li, M. W. Laird, M. Subramanian, M. Moayeri, S. H. Leppla, Y. Fitz, J. Su, K. Sherer and P. Q. Eichacker: Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. The Journal of infectious diseases, 195(4), 572-80 (2007) doi:10.1086/510856
41. A. Guichard, V. Nizet and E. Bier: New insights into the biological effects of anthrax toxins: linking cellular to organismal responses. Microbes Infect, 14(2), 97-118 (2012) doi:10.1016/j.micinf.2011.08.016
42. W. S. Lawrence, J. R. Marshall, D. L. Zavala, L. E. Weaver, W. B. Baze, S. T. Moen, E. B. Whorton, R. L. Gourley and J. W. Peterson: Hemodynamic effects of anthrax toxins in the rabbit model and the cardiac pathology induced by lethal toxin. Toxins (Basel), 3(6), 721-36 (2011)
43. D. A. Sweeney, X. Cui, S. B. Solomon, D. A. Vitberg, T. S. Migone, D. Scher, R. L. Danner, C. Natanson, G. M. Subramanian and P. Q. Eichacker: Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. J Infect Dis, 202(12), 1885-96 (2010)
44. Y. Li, K. Sherer, X. Cui and P. Q. Eichacker: New insights into the pathogenesis and treatment of anthrax toxin-induced shock. Expert Opin Biol Ther, 7(6), 843-54 (2007)
45. L. Borio, D. Frank, V. Mani, C. Chiriboga, M. Pollanen, M. Ripple, S. Ali, C. DiAngelo, J. Lee, J. Arden, J. Titus, D. Fowler, T. O'Toole, H. Masur, J. Bartlett and T. Inglesby: Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA, 286(20), 2554-9 (2001)
46. J. M. Warfel, A. D. Steele and F. D'Agnillo: Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol, 166(6), 1871-81 (2005)
47. F. D'Agnillo, M. C. Williams, M. Moayeri and J. M. Warfel: Anthrax lethal toxin downregulates claudin-5 expression in human endothelial tight junctions. PLoS One, 8(4), e62576 (2013)
48. Y. Gozes, M. Moayeri, J. F. Wiggins and S. H. Leppla: Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect Immun, 74(2), 1266-72 (2006)
49. T. Liu, E. Milia, R. R. Warburton, N. S. Hill, M. Gaestel and U. S. Kayyali: Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling. J Cell Physiol, 227(4), 1438-45 (2012)
50. J. H. Kau, D. S. Sun, W. J. Tsai, H. F. Shyu, H. H. Huang, H. C. Lin and H. H. Chang: Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets. J.Infect.Dis., 192(8), 1465-1474 (2005)
51. S. Alam, M. Gupta and R. Bhatnagar: Inhibition of platelet aggregation by anthrax edema toxin. Biochem Biophys Res Commun, 339(1), 107-14 (2006)
52. E. D. Boyden and W. F. Dietrich: Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat.Genet., 38(2), 240-244 (2006)
53. M. Moayeri, D. Crown, Z. L. Newman, S. Okugawa, M. Eckhaus, C. Cataisson, S. Liu, I. Sastalla and S. H. Leppla: Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog, 6(12), e1001222 (2010) doi:10.1371/journal.ppat. 1001222
54. J. L. Levinsohn, Z. L. Newman, K. A. Hellmich, R. Fattah, M. A. Getz, S. Liu, I. Sastalla, S. H. Leppla and M. Moayeri: Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog, 8(3), e1002638 (2012) doi:10.1371/journal.ppat.1002638
55. J. M. Park, V. H. Ng, S. Maeda, R. F. Rest and M. Karin: Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med, 200(12), 1647-55 (2004) doi:10.1084/jem.20041215
56. J. L. Erwin, L. M. DaSilva, S. Bavari, S. F. Little, A. M. Friedlander and T. C. Chanh: Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infection and immunity, 69(2), 1175-7 (2001) doi:10.1128/IAI.69.2.1175-1177.2001
57. R. Pellizzari, C. Guidi-Rontani, G. Vitale, M. Mock and C. Montecucco: Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett., 462(1-2), 199-204 (1999)
58. S. L. Fink and B. T. Cookson: Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infection and immunity, 73(4), 1907-16 (2005)
59. S. L. Fink and B. T. Cookson: Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol, 9(11), 2562-70 (2007)
60. S. L. Fink and B. T. Cookson: Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol, 8(11), 1812-25 (2006)
61. P. J. Sansonetti, A. Phalipon, J. Arondel, K. Thirumalai, S. Banerjee, S. Akira, K. Takeda and A. Zychlinsky: Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity, 12(5), 581-90 (2000)
62. C. L. Case, S. Shin and C. R. Roy: Asc and Ipaf Inflammasomes direct distinct pathways for caspase-1 activation in response to Legionella pneumophila. Infect Immun, 77(5), 1981-91 (2009)
63. T. Suzuki, L. Franchi, C. Toma, H. Ashida, M. Ogawa, Y. Yoshikawa, H. Mimuro, N. Inohara, C. Sasakawa and G. Nunez: Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog, 3(8), e111 (2007)
64. S. Mariathasan, D. S. Weiss, V. M. Dixit and D. M. Monack: Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med, 202(8), 1043-9 (2005)
65. G. W. Sun, J. Lu, S. Pervaiz, W. P. Cao and Y. H. Gan: Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei. Cell Microbiol, 7(10), 1447-58 (2005)
66. S. M. Muehlbauer, H. Lima, Jr., D. L. Goldman, L. S. Jacobson, J. Rivera, M. F. Goldberg, M. A. Palladino, A. Casadevall and J. Brojatsch: Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin. The American journal of pathology, 177(2), 735-43 (2010)
67. S. M. Muehlbauer, T. H. Evering, G. Bonuccelli, R. C. Squires, A. W. Ashton, S. A. Porcelli, M. P. Lisanti and J. Brojatsch: Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis. Cell Cycle, 6(6), 758-766 (2007)
68. F. S. Sutterwala, Y. Ogura, M. Szczepanik, M. Lara-Tejero, G. S. Lichtenberger, E. P. Grant, J. Bertin, A. J. Coyle, J. E. Galan, P. W. Askenase and R. A. Flavell: Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity, 24(3), 317-27 (2006)
69. L. P. Shornick, P. De Togni, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, T. A. Ferguson and D. D. Chaplin: Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med, 183(4), 1427-36 (1996)
70. T. Kawai, O. Adachi, T. Ogawa, K. Takeda and S. Akira: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity, 11(1), 115-22 (1999)
71. S. Mariathasan, K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson and V. M. Dixit: Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature, 430(6996), 213-8 (2004)
72. J. Sunden-Cullberg, A. Norrby-Teglund, A. Rouhiainen, H. Rauvala, G. Herman, K. J. Tracey, M. L. Lee, J. Andersson, L. Tokics and C. J. Treutiger: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med, 33(3), 564-73 (2005)
73. H. Wang, O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K. R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P. E. Molina, N. N. Abumrad, A. Sama and K. J. Tracey: HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285(5425), 248-51 (1999)
74. P. Scaffidi, T. Misteli and M. E. Bianchi: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418(6894), 191-5 (2002) doi:10.1038/nature00858
75. S. Makino, M. Watarai, H. I. Cheun, T. Shirahata and I. Uchida: Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. The Journal of infectious diseases, 186(2), 227-33 (2002) doi:10.1086/341299
76. J. Keppie, H. Smith and P. W. Harris-Smith: The chemical basis of the virulence of bacillus anthracis. II. Some biological properties of bacterial products. Br J Exp Pathol, 34(5), 486-96 (1953)
77. B. D. Green, L. Battisti, T. M. Koehler, C. B. Thorne and B. E. Ivins: Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun, 49(2), 291-7 (1985)
78. A. Scorpio, S. A. Tobery, W. J. Ribot and A. M. Friedlander: Treatment of experimental anthrax with recombinant capsule depolymerase. Antimicrob Agents Chemother, 52(3), 1014-20 (2008)
79. T. R. Kozel, P. Thorkildson, S. Brandt, W. H. Welch, J. A. Lovchik, D. P. AuCoin, J. Vilai and C. R. Lyons: Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule. Infect Immun, 75(1), 152-63 (2007)
80. P. Qiu, Y. Li, J. Shiloach, X. Cui, J. Sun, L. Trinh, J. Kubler-Kielb, E. Vinogradov, H. Mani, M. Al-Hamad, Y. Fitz and P. Q. Eichacker: Bacillus anthracis Cell Wall Peptidoglycan but Not Lethal or Edema Toxins Produces Changes Consistent With Disseminated Intravascular Coagulation in a Rat Model. J Infect Dis, 208(6), 978-89 (2013)
81. T. Kawai and S. Akira: Toll-like receptor downstream signaling. Arthritis Res Ther, 7(1), 12-9 (2005)
82. M. Langer, A. Malykhin, K. Maeda, K. Chakrabarty, K. S. Williamson, C. L. Feasley, C. M. West, J. P. Metcalf and K. M. Coggeshall: Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway. PLoS One, 3(11), e3706 (2008)
83. X. Cui, J. Su, Y. Li, J. Shiloach, S. Solomon, J. B. Kaufman, H. Mani, Y. Fitz, J. Weng, L. Altaweel, V. Besch and P. Q. Eichacker: Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model. Intensive Care Med, 36(1), 148-56 (2010)
84. X. Cui, Y. Li, M. Moayeri, G. H. Choi, G. M. Subramanian, X. Li, M. Haley, Y. Fitz, J. Feng, S. M. Banks, S. H. Leppla and P. Q. Eichacker: Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. J.Infect.Dis., 191(3), 422-434 (2005)
85. L. Vitale, D. Blanset, I. Lowy, T. O'Neill, J. Goldstein, S. F. Little, G. P. Andrews, G. Dorough, R. K. Taylor and T. Keler: Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity. Infect.Immun., 74(10), 5840-5847 (2006)
86. N. Mytle, R. J. Hopkins, N. V. Malkevich, S. Basu, G. T. Meister, D. C. Sanford, J. E. Comer, K. E. Van Zandt, M. Al-Ibrahim, W. G. Kramer, C. Howard, N. Daczkowski, A. C. Chakrabarti, B. Ionin, G. S. Nabors and M. H. Skiadopoulos: Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. Antimicrob Agents Chemother, 57(11), 5684-92 (2013)
87. G. M. Subramanian, P. W. Cronin, G. Poley, A. Weinstein, S. M. Stoughton, J. Zhong, Y. Ou, J. F. Zmuda, B. L. Osborn and W. W. Freimuth: A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers. Clin Infect Dis, 41(1), 12-20 (2005)
88. T. S. Migone, G. M. Subramanian, J. Zhong, L. M. Healey, A. Corey, M. Devalaraja, L. Lo, S. Ullrich, J. Zimmerman, A. Chen, M. Lewis, G. Meister, K. Gillum, D. Sanford, J. Mott and S. D. Bolmer: Raxibacumab for the treatment of inhalational anthrax. N.Engl.J.Med., 361(2), 135-144 (2009)
89. K. Sherer, Y. Li, X. Cui, X. Li, M. Subramanian, M. W. Laird, M. Moayeri, S. H. Leppla, Y. Fitz, J. Su and P. Q. Eichacker: Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Crit Care Med, 35(6), 1560-7 (2007)
90. Y. Li, X. Cui, J. Su, M. Haley, H. Macarthur, K. Sherer, M. Moayeri, S. H. Leppla, Y. Fitz and P. Q. Eichacker: Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats. Crit Care Med, 37(4), 1348-54 (2009)